Lundbeck
HLUN-B.CO
#2346
Rank
NZ$10.56 B
Marketcap
$10.92
Share price
0.98%
Change (1 day)
20.87%
Change (1 year)
Lundbeck is a Danish pharmaceutical company that produces various pharmaceutical products and has the indications schizophrenia, depression, Parkinson's disease and sleep disorders.

Earnings for Lundbeck (HLUN-B.CO)

Earnings in 2024 (TTM): NZ$0.77 B

According to Lundbeck 's latest financial reports the company's current earnings (TTM) are NZ$0.75 B. In 2023 the company made an earning of NZ$0.71 B an increase over its 2022 earnings that were of NZ$0.58 B.The earnings displayed on this page is the company's Pretax Income.

Earnings history for Lundbeck from 2009 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) NZ$0.77 B8.87%
2023 NZ$0.71 B21.69%
2022 NZ$0.58 B31.79%
2021 NZ$0.44 B-4.53%
2020 NZ$0.46 B-45.08%
2019 NZ$0.84 B-33.97%
2018 NZ$1.28 B12.76%
2017 NZ$1.14 B94.32%
2016 NZ$0.58 B-136.98%
2015 -NZ$1.59 B-1258.1%
2014 NZ$0.13 B-72.43%
2013 NZ$0.49 B4.31%
2012 NZ$0.47 B-55.26%
2011 NZ$1.06 B6.64%
2010 NZ$0.99 B-6.68%
2009 NZ$1.07 B